The Biden-McCarthy leaves $5 billion intact for coronavirus vaccine and treatment research, according to multiple media reports.
The debt-ceiling deal negotiated by President Joe Biden House Speaker Kevin McCarthy does not include the Medicaid work requirements that many Democrats were prepared to fight. But the agreement does include clawing back $30 billion in unspent COVID-19 relief funds favored by many Republicans.
The debt-ceiling bill passed by House Republicans in late April included Medicaid work requirements. The Kaiser Family Foundation estimated that if the requirements became law and had been implemented next year, up to 1.7 Medicaid enrollees might have lost coverage for failing to meet the requirements.
The Washington Post’s “The Health 202” email newsletter and other media outlets are reporting that the COVID-19 clawback does not affect the $5 billion allocated for research and development for next-generation coronavirus vaccines and treatments.
The Biden-McCarthy deal does, in fact, include an expansion of work requirements but for Supplemental Nutrition Assistance Program (SNAP), formerly known was food stamps, not Medicaid. Currently, the SNAP program has work requirements for individuals ages 18-49. The agreement, which must pass the House and the Senate to become law, would expand that age range to 18-54, with exceptions for veterans, people who are homeless and young people leaving foster care.
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More